Think IPO. Think IPOX®.
Specialized solutions for investors seeking exposure to the companies shaping what comes next.
IPOX® International Index
Tracked byFirst Trust International Equity Opportunities ETF FPXI ETF ↗
Upcoming listings
Blue Lagoon
Geothermal spas and hotels
HiJoJo Partners
Startup investing
Hasko
Niche products
METKA
Infrastructure construction
Japan Home Shield
Geotechnical and inspection services
Adel
Neurodegenerative medicines
NOTA
Accommodation and development
SmartNews
Mobile applications
WHI Holdings
Enterprise HR software
FOLIO Holdings
Financial technology
IG Holdings
IT hardware sales
INTERX
Manufacturing AI
12 upcoming listings
News
Money.ca: IPOX® VP Kat Liu Comments on Anthropic’s Record IPO and the Scrutiny Ahead
IPOX® VP Kat Liu was interviewed by Money.ca on Anthropic’s record IPO, which raised $81.3 billion at a valuation of approximately $1.5 trillion before the shares jumped more than 30% in their Nasdaq debut. Liu said the valuation already reflected exceptionally high expectations, that strong IPO demand does not guarantee equally strong returns, and that investors should watch margins, free cash flow and whether revenue growth can outpace the cost of AI models.
Nikkei: IPOX® CEO Josef Schuster Comments on Anthropic’s Nasdaq Debut and Short-Term Volatility
IPOX® CEO Josef Schuster was featured in Nikkei on Anthropic’s Nasdaq debut, the first mega IPO of a pure AI company, which coincided with a decline in the major U.S. indices. Schuster suggested investors may have sold other holdings to buy Anthropic, adding to market volatility. He expects the shares to remain volatile in the short term but sees a drop below the IPO price as unlikely, and flagged a future bond issue as a risk for the stock.
Reuters: IPOX® Associate Lukas Muehlbauer Comments on Investor Demand for Anthropic’s Record IPO
Reuters cited IPOX® Associate Lukas Muehlbauer ahead of Anthropic’s Nasdaq debut after the Claude maker raised a record $81 billion, pricing 980 million shares at $83, above its $70–$78 range, for a $1.5 trillion valuation. Muehlbauer noted that some of the demand may reflect investors not wanting to miss a rare chance to gain exposure to a leading AI company, even as its long-term profitability remains uncertain.
Reuters: IPOX® Associate Lukas Muehlbauer Comments on a Record but Selective U.S. IPO Market
Reuters cited IPOX® Associate Lukas Muehlbauer on a U.S. IPO market that has set fundraising records in 2026 while listing counts stay well below historical highs. Anthropic’s $81.3 billion IPO and SpaceX’s $75 billion offering carried proceeds past the 2021 record. Muehlbauer noted that the two deals will account for about two-thirds of the year’s proceeds and described 2026 as a selective reopening, with many companies now looking to 2027.
Bloomberg: IPOX® Associate Lukas Muehlbauer Comments on Airtel Money’s London Aftermarket Rebound
Bloomberg cited IPOX® Associate Lukas Muehlbauer on the recovery of African mobile money and payments provider Airtel Money after a shaky London debut. The shares closed at 226p on November 18, about 15% above the 196p IPO price, after trading more than 10% below it in the first week. Muehlbauer said investors appear increasingly confident in the company’s growth story, and that disciplined pricing in a buyer’s market left room for aftermarket gains, a good sign for London’s IPO pipeline.
Money Life with Chuck Jaffe: IPOX® CEO Josef Schuster Discusses Anthropic’s IPO
IPOX® CEO Josef Schuster joined Chuck Jaffe on the Money Life podcast on November 18 to discuss Anthropic’s upcoming IPO, the first large pure-play AI listing. Schuster compared the deal with SpaceX, expects the stock to be volatile until earnings provide a fundamental anchor, and explained why IPOX® treats IPOs as a separate equity sector for their first four years of trading. His segment starts at 7:00; the full transcript is included.
A world of new listings.
A disciplined approach.
New listings reflect economic growth and innovation. Our services bring a disciplined approach to this evolving global universe through independent research, index licensing, portfolio management and tailored investment solutions.
Explore our services